Lisocabtagene maraleucel (liso-cel) in R/R MCL: Primary analysis results from the mcl cohort of the single-arm, multicenter, phase I seamless design TRANSCEND NHL 001 study Meeting Abstract
| Authors: | Palomba, M. L.; Siddiqi, T.; Gordon, L. I.; Kamdar, M.; Lunning, M.; Hirayama, A. V.; Abramson, J. S.; Arnason, J.; Ghosh, N.; Mehta, A.; Andreadis, C.; Solomon, S. R.; Kostic, A.; Dehner, C.; Espinola, R.; Peng, L.; Ogasawara, K.; Chattin, A.; Wang, M. |
| Abstract Title: | Lisocabtagene maraleucel (liso-cel) in R/R MCL: Primary analysis results from the mcl cohort of the single-arm, multicenter, phase I seamless design TRANSCEND NHL 001 study |
| Meeting Title: | 11th Annual Meeting of the Society of Hematologic Oncology (SOHO 2023): Progress in Personalized Therapy |
| Keywords: | mantle cell lymphoma; phase i; refractory; mcl; car t-cell therapy; lisocabtagene maraleucel; relapsed or |
| Journal Title: | Clinical Lymphoma, Myeloma and Leukemia |
| Volume: | 23 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2023 Sep 6-9 |
| Meeting Location: | Houston, TX |
| ISSN: | 2152-2650 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2023-09-01 |
| Start Page: | S458 |
| Language: | English |
| ACCESSION: | WOS:001062479600503 |
| PROVIDER: | wos |
| DOI: | 10.1016/S2152-2650(23)01370-8 |
| Notes: | Meeting Abstract: MCL-096 -- Source: Wos |
